Toujeo Double Star
New: Toujeo: deux formats de stylos différents
- Moins de stylos, moins de stock et moins à emporter
- Plus de confort
- Une seule injection peut améliorer l’observance thérapeutique du patient1
.jpg0/jcr:content/image%20(3).jpg)
Toujeo DoubleStar FR v5
- Toujeo® European Summary of Product Characteristics
Taming Diabetes: A Daily Challenge for Martin and His Family
Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.
Living with T1D for 25 Years: Philippe's Inspiring Journey
At the dawn of his fifties, Philippe has tamed the diabetes he has lived with for over 25 years, along with his initial fear of injections. For him, this disease represents "a turning point, not an end." He leads a life "like everyone else," multiplying passions and fully enjoying every moment.
Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.1 The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.2 Assays for detecting autoimmune T1D have shown high sensitivity and specificity.3,4
Les contenus accessibles par ce site sont destinés exclusivement aux Professionnels de Santé.
Les contenus accessibles par ce site sont destinés
exclusivement aux Professionnels de Santé.
Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.